Efficacy assessment of cerebral arterial bypass surgery using statistical parametric mapping and probabilistic brain atlas on basal/acetazolamide brain perfusion SPECT

Journal of Nuclear Medicine

Volumn 45, Issue 2, 2004, Pages 202-206

  Lee, Ho Young ^a   Jin, Chul Paeng ^a   Dong, Soo Lee ^a   Jae, Sung Lee ^a   Chang, Wan Oh ^a   Maeng, Jae Cho ^a   Chung, June Key ^a   Myung, Chul Lee ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Brain perfusion SPECT; Cerebrovascular disease; Probabilistic brain atlas; SPM

Indexed keywords

ACETAZOLAMIDE; DIAGNOSTIC AGENT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ATLAS; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL CAROTID ARTERY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS; ALGORITHM; BRAIN; BRAIN MAPPING; CASE CONTROL STUDY; CEREBRAL REVASCULARIZATION; CLINICAL TRIAL; COMPUTER SIMULATION; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; STATISTICAL MODEL; VASCULARIZATION;

ACETAZOLAMIDE; ALGORITHMS; BRAIN; BRAIN ISCHEMIA; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBRAL REVASCULARIZATION; COMPUTER SIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 1542609236     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke. 2001;32:2110-2116.
2. Powers WJ, Grubb RL, Raichle ME. Clinical results of extracranial- intracranial bypass surgery in patients with hemodynamic cerebrovascular disease. J Neurosurg. 1989;70:61-67.
3. Klijn CJ, Kappelle LJ, van der Zwan A, van Gijn J, Tulleken CA. Excimer laser-assisted high-flow extracranial/intracranial bypass in patients with symptomatic carotid artery occlusion at high risk of recurrent cerebral ischemia: safety and long-term outcome. Stroke. 2002;33:2451-2458.
4. Ishikawa T, Houkin K, Abe H, Isobe M, Kamiyama H. Cerebral hemodynamics and long-term prognosis after extracranial-intracranial bypass surgery. J Neurol Neurosurg Psychiatry. 1995;59:625-628.
5. Schmiedek P, Piepgras A, Leinsinger G, Kirsch CM, Einhupl K. Improvement of cerebroperfusion reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. J Neurosurg. 1994;81:236-244.
6. Powers WJ, Press GA, Grubb RL Jr, Gado M, Raichle ME. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med. 1987;106:27-34.
7. Schroeder T. Cerebrovascular reactivity to acetazolamide in carotid artery disease: enhancement of side-to-side CBF asymmetry indicates critically reduced perfusion pressure. Neurol Res. 1986;8:231-236.
8. Vorstrup S. Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test. Acta Neurol Scand Suppl. 1988;114:1-48.
9. Ozgur HT, Kent Walsh T, Masaryk A, et al. Correlation of cerebroperfusion reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. Am J Neuroradiol. 2001;22:928-936.
10. Stockbridge HL, Lewis D, Eisenberg B, et al. Brain SPECT: a controlled, blinded assessment of intrareader and interreader agreement. Nucl Med Commun. 2002;23:537-544.
11. Lagreze HL, Levine RL, Sunderland JS, Nickles RJ. Pitfalls of regional cerebral blood flow analysis in cerebrovascular disease. Clin Nucl Med. 1988;13:197-201.
12. 99mTc]-HMPAO SPECT in occipital lobe epilepsy. Epilepsia. 2001;42:1531-1540.
13. 99mF-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med. 2002;43:1167-1174.
14. 99mTc]-HMPAO SPECT. Epilepsia. 2001;42:1515-1522.
15. 18F FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas. Neuroimage. 2001;14:1-6.
16. Lee SK, Lee DS, Yeo JS, et al. FDG PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy. Epilepsia. 2002;43:1032-1038.
17. 99mTc-HMPAO SPECT in patients with a chronically obstructed major cerebral artery. J Nucl Med. 1994;35:32-40.
18. 99mTc HMPAO SPECT in children with moyamoya disease. Korean J Nucl Med. 1998;32:314-324.
19. Kim JS, Lee JS, Kim YK, et al. Probabilistic anatomic map of blood flow distribution from internal carotid artery [abstract]. J Nucl Med. 2002;43(suppl):101P.
20. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N Engl J Med. 1985;313:1191-1200.
21. Kohno K, Oka Y, Kohno S, Ohta S, Kumon Y, Sakaki S. Cerebral blood flow measurement as an indicator for an indirect revascularization procedure for adult patients with moyamoya disease. Neurosurgery. 1998;42:752-757.
22. 99mTc-HMPAO SPECT and acetazolamide in childhood moyamoya disease. Stroke. 1996;27:282-289.
23. Yamashita T, Kashiwagi S, Nakashima K, et al. Modulation of cerebral hemodynamics by surgical revascularization in patients with moyamoya disease. Acta Neurol Scand Suppl. 1996;166:82-84.
24. Lagrese HL, Levine RL, Sunderland JS, Nickles RJ. Pitfalls of regional cerebral blood flow analysis in cerebrovascular disease. Clin Nucl Med. 1988;13:197-201.
25. 99mTc radiopharmaceuticals. Society of Nuclear Medicine. J Nucl Med. 1998;39:923-926.